[1]
«Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study», AJBR, vol. 22, n.º 3, pp. 347–352, dez. 2019, Acedido: 5 de abril de 2026. [Online]. Disponível em: https://ojshostng.com/index.php/ajbr/article/view/1335